NDC 16729-512 – Atropine Sulfate
Atropine Sulfate .4 mg/mL · Injection, Solution · Endotracheal, Intramedullary, Intramuscular, Intravenous, Subcutaneous
Product NDC16729-512
Product details
- Brand name
- Atropine Sulfate
- Generic name
- Atropine Sulfate
- Labeler
- Accord Healthcare Inc.
- Dosage form
- Injection, Solution
- Route
- Endotracheal, Intramedullary, Intramuscular, Intravenous, Subcutaneous
- Marketing category
- ANDA · ANDA213424
- Marketed since
- March 25, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anticholinergic; Cholinergic Muscarinic Antagonist
Active ingredients
- Atropine Sulfate .4 mg/mL
Uses, dosage, side effects and warnings for atropine sulfate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 16729-512-43 | 10 CARTON in 1 BOX (16729-512-43) / 1 VIAL, MULTI-DOSE in 1 CARTON (16729-512-05) / 20 mL in 1 VIAL, MULTI-DOSE | Mar 25, 2021 |
Recalls mentioning this NDC
- D-0917-2023 Jul 19, 2023 · Class II
Presence of Particulate Matter: Particulate matter identified as fiber.
Other atropine sulfate products
- 50090-5924 Atropine Sulfate .1 mg/mL · Injection · A-S Medication Solutions
- 16729-484 Atropine Sulfate .1 mg/mL · Injection · Accord Healthcare, Inc.,
- 16729-483 Atropine Sulfate .05 mg/mL · Injection · Accord Healthcare, Inc.,
- 0065-0817 Atropine Sulfate 10 mg/mL · Solution · Alcon Laboratories, Inc.
- 0517-1001 Atropine Sulfate 1 mg/mL · Injection, Solution · American Regent, Inc.
- 0517-1004 Atropine Sulfate .4 mg/mL · Injection, Solution · American Regent, Inc.
- 70121-1705 Atropine Sulfate .1 mg/mL · Injection, Solution · Amneal Pharmaceuticals LLC
- 70121-1706 Atropine Sulfate .1 mg/mL · Injection, Solution · Amneal Pharmaceuticals LLC
- 82260-001 Atropine Sulfate 10 mg/mL · Solution · Bausch & Lomb Americas Inc.
- 24208-825 Atropine Sulfate 10 mg/g · Ointment · Bausch & Lomb Incorporated
- 24208-965 Atropine Sulfate 10 mg/mL · Solution · Bausch & Lomb Incorporated
- 42799-826 Atropine Sulfate 10 mg/mL · Solution/ Drops · Edenbridge Pharmaceuticals LLC.